National and Kapodistrian University of Athens
Η ακτίνη και άλλα αντιγόνα του κυτταρικού σκελετού ως στόχοι φυσιολογικών και παθολογικών αυτοαντισωμάτων: Μελέτη σε ηπατικά νοσήματα και στη βαριά μυασθένεια
Abstract
dc:descriptionActin is one of the main constituents of the cytoskeleton found in all eukaryote cells and also arepresentative autoantigen, as a significantly high proportion of natural autoantibodies (NAbs)possess anti-actin activity. NAbs are found in all healthy individuals and are usually polyspecific. The earliest question raised since the discovery and isolation of NAbs has been their relationship with disease-associated autoantibodies (DAbs), which is of great importance for the understanding of the pathogenesis of autoimmune diseases. The main hypothesis, based on idiotypic and VHJHDH or VLJL gene similarities occurring between DAbs and NAbs, is that DAbs and their respective B-cell clones arise out of a population of B-lymphocytes originally committed to produce NAbs. The production of DAbs during disease may result from either of the following mechanisms: a) polyclonal activation of B-lymphocytes primarily producing NAbs; in this case, DAbs are polyspecific, like NAbs, b) specific antigen selection of Β lymphocytes primarily producing NAbs; in this case, some of the characteristics of DAbs are differentiated from those of NAbs (e.g. DAbs become monospecific, their fine specificity and/or isotype change, somatic mutations are accumulated on their CDR3 sequences). In addition, induced antibodies have also been correlated with NAbs; it has been proposed that antibodies induced after immunization with the autoantigen, derive from the same B-cell clones which primarily produce NAbs, but under the antigen pressure, they are differentiated (as compared to NAbs) through the accumulation of somatic mutations on their V genes. Based on actin being a representative self-antigen, the aims of this study were: 1) To investigate the relationship between natural anti-actin antibodies (N-AAA) (from sera of healthy donors) and disease associated AAA (D-AAA) from patients with autoimmune hepatitis type 1 (AIH-1) 2) To investigate the relationship between N-AAA (from sera before immunization) and induced AAA (produced after immunization of rabbits with actin). For this purpose, we compared the immunological properties: a) polyspecificity, b) fine specificity (recognized epitopes of actin) and c) isotype (IgG class and IgG subclasses), between the three populations of AAA (N-AAA, D-AAA and induced), which are isolated on actin immunoadsorbent from the respective sera and antisera. During the first part of this study, IgG AAA were isolated from patients with AIH-1 (AAA are considered as a marker AIH-1 and are associated with a more severe outcome of this disease). AAA were also isolated from two other control groups, an autoimmune liver disease, primary biliary cirrhosis (PBC) and an non-liver autoimmune disease, myasthenia gravis (MG). AAA have also been detected in the above diseases, but less frequently and in lower titer than in AIH-1. Polyspecificity was studied by ELISA based on actin and other cytoskeleton (myosin, tropomyosin, desmin and tubulin) and non-cytoskeleton antigens (thyroglobulin). Fine specificity was primarily studied by Western blotting using proteolytic fragments of actin (produced after its digestion by Staphylococcus aureus V8 protease) and subsequently by ELISA against 12-peptides of actin (which cover the whole actin sequence). The concentration of AAA of different IgG subclasses was measured using a quantitative ELISA. Results from the comparison between N-AAA and D-AAA revealed both similarities and differences. a) Both N-AAA and D-AAA are polyspecific, reacting with the autologous antigen (actin) and several heterologous antigens. b) AAA from all disease groups and healthy controls, recognize common epitopes on actin molecule, contained in the 35 kDa fragment of actin (which comprises a great part of actin sequence, at least to 337aa). However, AAA from the two autoimmune liver diseases are differentiated from NAbs and AAA from MG, as they specifically react against epitopes contained in the fragment of 16 kDa (229-377aa) and peptide P36 (351-362aa). No difference in fine specificity was found between AAA from AIH-1 and PBC. c) AAA from all disease groups and healthy controls, contain all four IgG subclasses.Nevertheless, IgGl and IgG3 are specifically increased in AAA from AIH-1 and PBC, respectively, as compared to N-AAA and AAA from MG. These are the two subclasses activating the complement and having a potential role in pathogenesis. No difference was noticed between N-AAA and AAA from MG. In the second part of this study, N-AAA were isolated on actin immunoadsorbent from the preimmune sera and induced AAA were isolated from the antisera of the primary (first immunization) and secondary immune response (immunization stage representing the highest response). Subsequently, the immunological properties of N-AAA and induced AAA were compared, using the same methodology as for D-AAA. Results showed that induced AAA which are produced during the secondary immune response, are differentiated under the antigen pressure, from N-AAA and AAA of the primary immune response: they become monospecific with different fine specificity, as they react against additional epitopes contained in the central sequence of actin. In addition, induced AAA have different characteristics as compared to DAAA from AIH-1 and PBC, as the former do not recognize the proteolytic fragment of 16 kDa or peptide P36. The above result suggests that the antigenic stimulus during the course of the disease differs from that used during the immunization process (e.g. actin modified by viral antigens). Finally, using new and sensitive immunological methods, developed during this study and having available the specific material (patients' sera and normal sera), we were able to make some clinical correlations between AIH-1 and other liver diseases, autoimmune (like PBC) and non-autoimmune (like viral hepatitis Β and C). Using the routine diagnostic tests, serological similarities are frequently found between AIH-1 and the other liver diseases. Consequently, the aim of these clinical correlations was to identify a specific immunological marker, in order to clearly diversify AIH-1 from the other liver diseases and improve its diagnosis. For this purpose, we analyzed the antigenic targets of autoantibodies from the above-mentioned diseases and we compared the diagnostic value of classical indirect immunofluorescence (IFL) on tissue sections (which detects anti-smooth muscle antibodies-ASMA, frequently correlated with anti-cytoskeleton antibodies-ACTA) with that of the following tests (which detect ACTA): 1) ELISA based on purified cytoskeleton antigens (actin, myosin, tropomyosin, troponin, vimentin, keratin and desmin), 2) ELISA based on HEp-2 cytoplasmic extract which contains several cytoskeleton proteins (HEp-2 is a carcinoma epithelial cell line from human larynx, frequently used in IFL for the detection of ACTA) and 3) Western blotting on HEp-2 cytoplasmic extract. Results showed that only IFL and ASMA are able to differentiate AIH-1 from the other two liver diseases. However, using the sensitive methods of ELISA and Western blotting, we were able to detect AAA and ACTA, in all liver diseases and thus showed that the immunological overlapping between AIH-1 and PBC is greater than initially found when detecting other groups of autoantibodies (ASMA or anti-mitochondrial antibodies/AMA). To conclude, AAA occurring in autoimmune liver diseases consist of at least two populations: one which shares common characteristics (polyspecificity, fine specificity and subclasses) with N-AAA and another which is differentiated in both fine specificity and subclasses from NAAA. The same was observed for induced AAA, which during the immunization process are differentiated from N-AAA (they become monospecific with different fine specificity). For the first time the epitopes of autoantibodies and induced antibodies against actin were mapped and an epitope, contained in the C-terminus of actin (351-362aa) and specific only for AAA from AIH-1 and PBC, was recognized. On the contrary, induced AAA recognize epitopes which are contained in the N-terminal and central sequence of actin. The two liver diseases were not differentiated, neither on terms of AAA fine specificity nor on terms of AAA titer. Future studies focusing on the immunogenicity of the P36 peptide in experimental animals or the cross-reactivity between anti-P36 AAA and liver-specific antigens, could explain their role in pathogenesis and their relationship with a severe outcome of AIH-1.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ζαμάνου, Αγγελική
- Zamanou, Angeliki
Subjects
dc:subject × 4Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/13594